Drug Treatment Options for Irritable Bowel Syndrome: Managing for Success

ISSN： 1170-229X

Source： Drugs & Aging, Vol.18, Iss.3, 2001-03, pp. : 201-211

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment Options for Irritable Bowel Syndrome Set to Increase

Pharmaceutical & Diagnostic Innovation, Vol. 2, Iss. 1, 2004-05 ,pp. : 12-17

Adis International

Access to resources Recommend Favorite

Renzapride: a new drug for the treatment of constipation in the irritable bowel syndrome

By Scarpellini Emidio Tack Jan

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 11, 2008-11 ,pp. : 1663-1670

Informa Healthcare

Access to resources Recommend Favorite

Rifaximin for the treatment of irritable bowel syndrome

By Cremonini Filippo Lembo Anthony

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 3, 2012-02 ,pp. : 433-440

Informa Healthcare

Access to resources Recommend Favorite

Asimadoline in the treatment of irritable bowel syndrome

By Mangel Allen W Williams Valerie SL

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 10, 2010-10 ,pp. : 1257-1264

Informa Healthcare

Access to resources Recommend Favorite

Review of tegaserod in the treatment of irritable bowel syndrome

By Patel Sonal Berrada Driss Lembo Anthony

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 11, 2004-11 ,pp. : 2369-2379

Informa Healthcare

Access to resources Recommend Favorite